SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: StockDung7/20/2005 9:04:30 AM
   of 150070
 
Pres/CEO Michael D. Mitchell M.D. stated "it gives me great satisfaction that the Pickens group believes as strongly as I do in this merger between LCSG Golf and T-19 Incorporated (Tubercin). I look foward to working with Michaell O. Pickens and the Pickens group.

SOURCE: LCS Golf, Inc., (LCSG - OTCBB)

Pickens Group makes equity investment in LCS Golf (LCSG OTC:BB)

BUSINESS WIRE--April 2, 2002--Pickens makes investment in LCS Golf (LCSG OTC:BB)

Pickens Group has purchased 2,000,000 shares of restricted 144 stock for $1,000,000. LCSG will use the proceeds from the equity investment to complete the acquisition of T-19. t-19.com

T-19 Incorporated will become a subsidery of LCSG golf. LCS Golf intends on changing its name to T-19 Incorporated.
T-19 Incorporated holds the worldwide distribution rights for T-19. (http://www.T-19.com) T-19 is a Nasal Spray comprised of a natural compound called Tubercin(www.tubercin.com), which enjoys US and other foreign patents. The T-19 Nasal Spray will be marketed worldwide through traditional retail distribution networks as a holistic treatment. T-19 may enhance the human immune system and help improve overall health. T-19 is natural and has no known adverse side effects.

Michael O. Pickens, son of T. Boone Pickens and CEO of Pickens Group, said " T-19 is a very exciting acquisition for LCS Golf, and I am very pleased to be part of the deal . Dr. Michael Mitchell and his team are great to work with and I look forward to an extremely successful expansion of T-19." The Pickens Group invests debt / equity capital in private / public companies and manages the group of M3 hedge funds.

Michael O. Pickens and Dr Mitchell will be leading the group and working directly with LCSG to present the Company to larger financial institutions.

Pres/CEO Michael D. Mitchell M.D. stated "it gives me great satisfaction that the Pickens group believes as strongly as I do in this merger between LCSG Golf and T-19 Incorporated (Tubercin). I look foward to working with Michaell O. Pickens and the Pickens group.
T-19 (Tubercin) is a neutraceuticle product, it is taken as a nasal spray and helps support a healthy immune system.

The Pickens Group LLC has been very successful in presenting companies to the financial community and this unique opportunity gives LCS Golf, (LCSG OTCBB) not only a strong investor but also a very strong circle of influence to open doors as we launch our products, Said Dr Michael Mitchell, CEO of LCS Golf.

Dr. Ronald Shinn President and CEO of T-19 incorporated comments, "We are delighted with LCS Golf and Dr. Michael Mitchell for furthering our capabilities with their expertise and resources to help bring T-19 to the market."
Disclaimer: Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements.

CONTACT: TEL: 866/523-5800 T-19 Incorporated, Honolulu
Eric Schopfer
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext